Immunotherapy of leukaemia.
D000328:Adult; D000818:Animals; D001500:BCG Vaccine / Q000627:therapeutic use; D064987:Cell- and Tissue-Based Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004357:Drug Synergism; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy; D007938:Leukemia / Q000628:therapy*; D007939:Leukemia L1210 / Q000628:therapy; D007942:Leukemia, Experimental / Q000628:therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000532:radiotherapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000532:radiotherapy; D051379:Mice; D009368:Neoplasm Transplantation; D012313:RNA / Q000627:therapeutic use
D001500:BCG Vaccine; D007166:Immunosuppressive Agents; D012313:RNA; D003520:Cyclophosphamide